TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biovica International AB
Closing information (x1000 DKK)
| Closing information | 2024/04 (consolidated) | 2023/04 (consolidated) | 2022/04 (consolidated) |
| Turnover |
4,626
|
2,227
|
1,476 |
| Financial expenses |
183
|
325
|
57 |
| Earnings before taxes |
-78,775
|
-72,857
|
-43,297 |
| EBITDA |
-74,511
|
-67,303
|
-38,729 |
| Total assets |
83,390
|
113,411
|
109,435 |
| Current assets |
55,917
|
78,985
|
68,501 |
| Current liabilities |
17,953
|
15,560
|
11,615 |
| Equity capital |
61,327
|
91,259
|
89,557 |
| - share capital |
3,556
|
2,007
|
1,371 |
| Employees (average) |
37
|
31
|
25 |
Financial ratios
| Fiscal year | 2024/04 (consolidated) | 2023/04 (consolidated) | 2022/04 (consolidated) |
| Solvency |
73.5%
|
80.5%
|
81.8% |
| Turnover per employee |
125
|
72
|
59 |
| Profit as a percentage of turnover |
-1702.9%
|
-3271.5%
|
-2933.4% |
| Return on assets (ROA) |
-94.2%
|
-64.0%
|
-39.5% |
| Current ratio |
311.5%
|
507.6%
|
589.8% |
| Return on equity (ROE) |
-128.5%
|
-79.8%
|
-48.3% |
| Change turnover |
2,479
|
881
|
-23 |
| Change turnover % |
115%
|
65%
|
-2% |
| Chg. No. of employees |
6
|
6
|
5 |
| Chg. No. of employees % |
19%
|
24%
|
25% |
Total value of public sale
| Fiscal year | 2024/04 (consolidated) | 2023/04 (consolidated) | 2022/04 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.